SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): November 29, 2012
SCIENTIFIC INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)
Delaware 000-6658 04-2217279
___________ ____________ __________________
(State or other (Commission (IRS Employer No.)
jurisdiction of File Number)
70 Orville Drive
Bohemia, New York 11716
(Address of principal executive offices)
Registrant's telephone number, including area code
(Former name or former address,
if changed since last report)
ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
The Company has agreed to a one-year extension through December
31, 2013 of the Fifth Amended and Restated Consulting
Agreement with Joseph G. Cremonese, the Chairman of its Board of
Directors, and his affiliate, Laboratory Innovations Company, Ltd.
on the same terms as the Fifth Amended and Restated Consulting
Agreement. Accordingly, the compensation will continue to be
$3,300 per month subject to an increase or decrease in the event
services are more than 60 days during the 12 month period at the
guaranteed rate of $660 per day. Either the Company or the
Consultant may terminate the Agreement, except for their
confidentiality and non-competition covenants on at least 60 days
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
At the Annual Meeting of Stockholders of the Company held on November
29, 2012, the stockholders took the following actions:
1. Elected Ms. Helena R. Santos and Mr. James S. Segasture as Class A
Directors to serve until the Annual Meeting of Stockholders for the
year ending June 30, 2015 by the following votes:
For Withheld Broker Non-Votes
Helena R. Santos 408,366 17,422 317,482
James S. Segasture 425,366 422 317,482
2. Approved by a vote of 742,346 shares for, 126 shares against, 12,798
shares abstaining, and 12,00 shares of Broker non-votes the appointment
by the Board of Directors of Nussbaum Yates Berg Klein & Wolpow, LLP as
the Company's independent registered public accounting firm with respect
to the Company's financial statements for the year ending June 30, 2013.
ITEM 9.01 Financial Statements and Exhibits
(a) and (b) not applicable
Exhibit No. Exhibit
10A-1 Copy of Extension Agreement between
the Company and the Consultant
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
SCIENTIFIC INDUSTRIES, INC.
Date: December 4, 2012
By: /s/ Helena R. Santos
Helena R. Santos,
President and Chief Executive Officer
This web site and associated pages are not associated with, endorsed by, or sponsored by SCIENTIFIC INDUSTRIES INC and has no official or unofficial affiliation with SCIENTIFIC INDUSTRIES INC
Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site. Use at your own risk.
This website is not associated with the SEC
Some parts © 2013 Advameg, Inc.